ACESO LIFE SCI (00474) plans to delay the publication of its full-year performance for 2026.

09:22 02/07/2026

China Life Science Technology (00474) issues announcement. The board of directors hereby notifies the shareholders that the company will not be able to publish the annual results for the year 2026 by June 30, 2026, as required by rules 13.49(1) and (2) of the Listing Rules. This is because the company needs additional time to collect and organize necessary information (including but not limited to valuations of certain financial assets, associated companies, and investment properties) for the auditors to complete the audit of the annual results for the year 2026.

ACESO LIFE SCI (00474) announces that the Board of Directors of the Company hereby informs the shareholders of the Company that the Company will not be able to publish the annual results for the year 2026 by June 30, 2026 in accordance with Rules 13.49(1) and (2) of the Listing Rules. This is because the Company needs additional time to collect and organize the necessary information (including but not limited to the valuation of certain financial assets, associates and investment properties) for the auditors to complete the audit work on the annual results for the year 2026.

JP Morgan raises CICC's target price to 28.5 Hong Kong dollars and maintains a "buy" rating.

HK Stock Market Move | BYD COMPANY (01211) rose more than 8% in early trading, with overseas sales in June nearly doubling year-on-year. It is expected that the full-year overseas sales will exceed expectations.

GF SEC: The three-way resonance of tin paste volume, price and profits, domestic alternatives have great potential.

JP Morgan raises CICC's target price to 28.5 Hong Kong dollars and maintains a "buy" rating.

GF SEC: The three-way resonance of tin paste volume, price and profits, domestic alternatives have great potential.